(Q34393564)

1 August 2017

title

Natural history and prognostic factors for chronic hepatitis type B (English)

1 reference

1 August 2017

1 reference

Fattovich G

1

1 reference

1 August 2017

Brollo L

2

1 reference

1 August 2017

Giustina G

3

1 reference

1 August 2017

Noventa F

4

1 reference

1 August 2017

Pontisso P

5

1 reference

1 August 2017

Alberti A

6

1 reference

1 August 2017

Realdi G

7

1 reference

1 August 2017

Ruol A

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1991

1 reference

1 August 2017

1 reference

1 August 2017

volume

32

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

294-298

1 reference

Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Long-term follow-up of anti-HBe-positive chronic active hepatitis B.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Long-term follow-up of chronic active hepatitis of moderate severity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378837

Natural history of hepatitis-associated antigen-positive chronic liver disease

27 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

The Natural Course of Hepatitis B Surface Antigen—Positive Chronic Active Hepatitis in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Acute and chronic hepatitis revisited. Review by an international group

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013423

12 December 2020

Identifiers

DOI

10.1136/GUT.32.3.294

1 reference

1 August 2017

1 reference

1 August 2017

1 reference